Brown Regina Insider Trades

Insider Trading History

Track insider trading activity for Brown Regina. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $89.7k 12,600 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.6k 22,600 shares
$0.91
$7.12
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $278 12,600 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$646 22,600 shares
$0.03
$0.02
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $67.7k 9,508 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 9,508 shares
$1.21
$7.12
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $210 9,508 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$321 9,508 shares
$0.03
$0.02
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $109 4,924 shares
Last Trade
Jan 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123 4,924 shares
$0.02
$0.02
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $35.1k 4,924 shares
Last Trade
Jan 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 4,924 shares
$2.33
$7.12
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $44.6k 6,269 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.7k 6,269 shares
$1.87
$7.12
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $139 6,269 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$256 6,269 shares
$0.04
$0.02
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $221 10,000 shares
Last Trade
Jun 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$894 14,904 shares
$0.06
$0.02
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $71.2k 10,000 shares
Last Trade
Jun 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.3k 14,904 shares
$2.37
$7.12
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $71.2k 10,000 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.8k 10,000 shares
$5.88
$7.12
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $221 10,000 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$900 10,000 shares
$0.09
$0.02
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $139 6,300 shares
Last Trade
Nov 21, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$425 5,000 shares
$0.08
$0.02
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $44.9k 6,300 shares
Last Trade
Nov 21, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.9k 5,000 shares
$0.58
$7.12
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $2.21k 100,000 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12k 100,000 shares
$0.12
$0.02
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $712k 100,000 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.5k 100,000 shares
$0.74
$7.12
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $712k 100,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$303k 100,000 shares
$3.03
$7.12
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $2.21k 100,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.6k 100,000 shares
$0.77
$0.02
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings LIXT
Director
Holding Value $9.26k 1,300 shares
Last Trade
May 11, 2011 Sale
$245k 250,000 shares
$0.98
$7.12
Lixte Biotechnology Holdings- Warrants (01/01/2025)
Lixte Biotechnology Holdings- Warrants (01/01/2025) LIXTW
Director
Holding Value $28.7 1,300 shares
Last Trade
May 11, 2011 Sale
No data
No data
$0.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up